Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside / BroadcastMed
Search
Close
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Access
All
Content accessible to Me
Refine by Date
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
—
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://jnccn.org/browse?access=all&page=10&pageSize=10&sort=datedescending
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Browse
You are looking at
91
-
100
of
4,190
items for
Refine by Access: All
x
Clear All
Items per page
10
20
50
Sort by
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
5
6
7
8
9
10
11
12
13
14
15
...
Full access
CLO23-038: The Impact of Dysbiosis Agents on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Melanoma Patients: A Systematic Review With Meta-Analysis
Chin-Hsuan Huang, Andrea S. Porpiglia, Yi-No Kang, Yu Chang, Tsu-Hsien Wang, and Kuan-Yu Chi
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-039: Safety Profile of Sonic Hedgehog Inhibitors in Basal Cell Carcinoma: A Systematic Review
Muhammad Zain Farooq, Mishal Shan Siddiqui, Syed Ali Farhan, Mahima Khatri, Syed Hamza Bin Waqar, Saad Khalid, and Ankit Mangla
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-040: Electrocardiographic Findings in Cancer Patients Receiving Chemotherapy From the Colombian Coffee Triangle Region
Andres Garcia, David Medina, Alejandra Palacio, Andrés Vallejo, Luz Adriana Díaz, Juan Darío Franco, Tatiana Taborda, and María José Rojas
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-041: Cardiovascular Event Risk Following Androgen Deprivation Therapy Initiation by Personal History of Cardiovascular Events
Przemyslaw Twardowski, Stuart Atkinson, and Deborah Boldt-Houle
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-042: Clinical Outcomes of Radical Radiotherapy With or Without Chemotherapy in Inoperable Locally Advanced Squamous Cell Carcinoma of Oral Cavity
Maria Philip, Jomon Raphael Chalissery, Febin Antony, Rajkrishna B, and Mathew Varghese K
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-043: Optimal Interval Between Immune Therapy and Targeted Therapy With Sotorasib in Patients With
KRAS G12C
Mutant Non–Small Cell Lung Cancer
Julia Bielanin, Wade T. Iams, Heidi Chen, and Amanda Cass
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-045: A Prospective Interventional Study to Assess the Response of Systemic Chemotherapy in Aggressive, Recurrent Giant Cell Tumor
Mohit Dhingra, Saroj Sah, Amit Sehrawat, and Sonal Saran
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-046: Pooled Outcomes of Anti-BRAF Agents in Advanced Stage Colorectal Cancer
Mackenzie Taychert, Ankita Aggarwal, David Tabagari, Urja Nagadia, Sai Gajagowni, Venkata Vosuri, and Kushal Naha
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-047: Ivosidenib as a Novel Treatment for Patients With Isocitrate Dehydrogenase-1 Positive Advanced Colon Cancer
Krishna Desai, Kristal Pereira, Akhil Jain, Sabah Iqbal, and Rajesh Thirumaran
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Full access
CLO23-048: Disparities in Outcomes of Chemotherapy-Related Febrile Neutropenia Patients: A Nationwide Study of Hospitalizations
Akhil Jain, Sohiel Deshpande, Krishna Desai, Sabah Iqbal, Aisha Sultan, Monika Garg, Bohdan Baralo, and Rajesh Thirumaran
In
Journal of the National Comprehensive Cancer Network Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Virtual Annual Conference
31 Mar 2023
Items per page
10
20
50
Sort by
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
5
6
7
8
9
10
11
12
13
14
15
...
[44.200.145.223]
44.200.145.223
